Clinical trial
Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease
NCT05014555 is registered in ClinicalTrials.gov with GI Alliance as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease
- Lead sponsor
- GI Alliance
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 5, 2023
- Completion date
- January 31, 2024
- Enrollment
- 400 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.